Gene therapy with hepatocyte growth factor in critical limb ischemia

2020, Number 3

Rev Cub Med Int Emerg 2020; 19 (3)

Martínez-Pizarro S

Language: Spanish
References: 5
Page: 1-4
PDF size: 116.53 Kb.

Text Extraction

No abstract.

REFERENCES

Lin XY, Wang H, Tan Y. Role of Hepatocyte Growth Factor in Wound Repair. Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2018;40(6):822-6. Doi: 10.3881/j.issn.1000-503X.10246.
Ylä-Herttuala S. Gene Therapy of Critical Limb Ischemia Enters Clinical Use. Mol Ther. 2019;27(12):2053. Doi: 10.1016/j.ymthe.2019.11.001.
Gu Y, Cui S, Wang Q, Liu C, Jin B, Guo W, et al. A Randomized, Double-Blind, Placebo-Controlled Phase II Study of Hepatocyte Growth Factor in the Treatment of Critical Limb Ischemia. Mol Ther. 2019;27(12):2158-65. Doi: 10.1016/j.ymthe.2019.10.017.
Kibbe MR, Hirsch AT, Mendelsohn FO, Davies MG, Pham H, Saucedo J, et al. Safety and efficacy of plasmid DNA expressing two isoforms of hepatocyte growth factor in patients with critical limb ischemia. Gene Ther. 2016;23(3):306-12. Doi: 10.1038/gt.2015.110.
Cui S, Guo L, Li X, Gu Y, Fu J, Dong L, et al. Clinical Safety and Preliminary Efficacy of Plasmidp UDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia. Eur J Vasc Endovasc Surg. 2015;50(4):494-501. Doi: 10.1016/j.ejvs.2015.05.007.